Confluent, Inc. $CFLT Shares Sold by Amundi

Amundi reduced its holdings in shares of Confluent, Inc. (NASDAQ:CFLT - Free Report) by 0.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,986,204 shares of the company's stock after selling 15,841 shares during the quarter. Amundi owned approximately 0.58% of Confluent worth $46,557,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of CFLT. 1832 Asset Management L.P. bought a new stake in Confluent during the first quarter worth $48,547,000. Vanguard Group Inc. lifted its holdings in Confluent by 7.2% during the first quarter. Vanguard Group Inc. now owns 26,620,150 shares of the company's stock worth $623,976,000 after acquiring an additional 1,791,588 shares during the period. Driehaus Capital Management LLC bought a new stake in Confluent during the first quarter worth $39,944,000. Phoenix Financial Ltd. lifted its holdings in Confluent by 901.4% during the first quarter. Phoenix Financial Ltd. now owns 1,547,112 shares of the company's stock worth $36,269,000 after acquiring an additional 1,392,615 shares during the period. Finally, Nuveen LLC bought a new stake in Confluent during the first quarter worth $28,791,000. 78.09% of the stock is currently owned by institutional investors.

Confluent Stock Down 2.6%

Shares of Confluent stock traded down $0.53 during trading hours on Thursday, reaching $19.49. 3,753,455 shares of the company were exchanged, compared to its average volume of 6,687,458. Confluent, Inc. has a 1 year low of $15.64 and a 1 year high of $37.90. The stock's fifty day moving average is $21.15 and its 200 day moving average is $22.99. The company has a debt-to-equity ratio of 1.03, a quick ratio of 3.98 and a current ratio of 3.98. The firm has a market cap of $6.72 billion, a PE ratio of -20.75 and a beta of 0.97.

Confluent (NASDAQ:CFLT - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.08 by $0.01. The firm had revenue of $282.29 million for the quarter, compared to analyst estimates of $278.32 million. Confluent had a negative return on equity of 27.34% and a negative net margin of 29.27%.Confluent's revenue for the quarter was up 20.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.06 earnings per share. Confluent has set its Q3 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.360-0.360 EPS. As a group, equities research analysts forecast that Confluent, Inc. will post -0.83 earnings per share for the current year.

Insider Transactions at Confluent

In related news, CRO Ban Ryan Norris Mac sold 15,200 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $17.01, for a total value of $258,552.00. Following the transaction, the executive owned 397,345 shares of the company's stock, valued at $6,758,838.45. This represents a 3.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Rohan Sivaram sold 26,097 shares of the stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $17.01, for a total value of $443,909.97. Following the completion of the transaction, the chief financial officer directly owned 636,596 shares in the company, valued at $10,828,497.96. This trade represents a 3.94% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 587,421 shares of company stock valued at $10,554,916 over the last ninety days. Company insiders own 9.20% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on CFLT. Barclays decreased their target price on Confluent from $31.00 to $24.00 and set an "overweight" rating for the company in a research report on Friday, August 1st. Piper Sandler decreased their target price on Confluent from $32.00 to $27.00 and set an "overweight" rating for the company in a research report on Thursday, July 31st. Wells Fargo & Company decreased their target price on Confluent from $30.00 to $27.00 and set an "overweight" rating for the company in a research report on Thursday, July 31st. Cowen downgraded Confluent from a "buy" rating to a "hold" rating in a research report on Thursday, July 31st. Finally, Needham & Company LLC decreased their target price on Confluent from $26.00 to $24.00 and set a "buy" rating for the company in a research report on Thursday, July 31st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $27.36.

Confluent Company Profile

Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.